Results 131 to 140 of about 15,769 (235)

Will European Consumers and Stakeholders accept New Genomic Techniques (NGTs) in Food Production? Les consommateurs et les parties prenantes européens accepteront‐ils les nouvelles techniques génomiques (NTG) dans la production alimentaire ? Werden europäische Verbraucher und Interessengruppen neue genomische Verfahren (NGV) in der Lebensmittelproduktion akzeptieren?

EuroChoices, EarlyView.
Summary New Genomic Techniques (NGTs) can be an important tool to achieve the goals set out in the European Green Deal like food security, environmental sustainability and climate change adaptation. However, the success of NGT‐derived products in the market depends on their acceptance by consumers and stakeholders.
Jan Pokrivcak, Miroslava Rajcaniova, Ema Lazorcakova   +2 more
wiley   +1 more source

Healthcare efficiency assessment using DEA analysis in the Slovak Republic. [PDF]

Health Econ Rev, 2018
Stefko R, Gavurova B, Kocisova K.
europepmc   +1 more source

Agri‐food Trade between Visegrad Countries and Taiwan: Opportunities, Limitations and Twists and Turns Commerce agroalimentaire entre les pays du groupe de Visegrad et Taïwan : Opportunités, limites et rebondissements Agrar‐ und Lebensmittelhandel zwischen den Visegrad‐Ländern und Taiwan: Chancen, Grenzen und Wendungen

EuroChoices, EarlyView.
Summary This study examines the dynamics and potential of agri‐food trade between the Visegrad Four (V4) countries and Taiwan, using this regional case to highlight broader opportunities for EU–Taiwan economic engagement. While the V4 countries have not historically been major agri‐food trading partners with Taiwan, the analysis reveals untapped trade ...
Ivo Zdrahal, Chia‐Lin Chang
wiley   +1 more source

Development of Regional Disparities in Alzheimer's Disease Mortality in the Slovak Republic from 1996 to 2015. [PDF]

Int J Alzheimers Dis, 2018
Gavurová B, Kováč V, Jarčušková D.
europepmc   +1 more source

Tax Planning Under Pressure: The Impact of Carbon Emissions Management Post‐Paris Agreement

Accounting &Finance, EarlyView.
ABSTRACT We examine how the Paris Agreement affects corporate tax planning across a global data set. We find that emissions‐reducing firms are associated with higher levels of tax planning than nonemissions‐reducing firms. The effect is stronger for firms facing tighter cost pass‐through constraints, such as operating in more competitive markets, with ...
Aonan (Sistine) Sun, Yuan George Shan, Lyndie Bayne, Nishant Agarwal   +3 more
wiley   +1 more source

Regional disparities in medical equipment distribution in the Slovak Republic - a platform for a health policy regulatory mechanism. [PDF]

Health Econ Rev, 2017
Gavurová B, Kováč V, Fedačko J.
europepmc   +1 more source

Update on Non‐Biological and RNA‐Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter, I. M. Adcock, C. Benito‐Villalvilla, R. Bianchini, L. Bjermer, G. Caramori, L. Cari, K. F. Chung, Z. Diamant, I. Eguiluz‐Gracia, E. F. Knol, M. Jesenak, F. Levi‐Schaffer, G. Nocentini, L. O'Mahony, O. Palomares, F. Redegeld, M. Sokolowska, B. Van Esch, M. Zurlo, C. Stellato   +20 more
wiley   +1 more source

Exploring market dynamics of biological including biosimilar treatments for retinal diseases in Europe: An interrupted time‐series analysis

Acta Ophthalmologica, EarlyView.
Abstract Purpose To assess the impact of biosimilar ranibizumab and on‐patent faricimab market entry on pricing and utilization trends and describe national variation in off‐label bevacizumab use in Europe. Methods Interrupted time series analysis of quarterly sales data (Q1 2018–Q2 2024) in 11 European countries evaluated ranibizumab utilization and ...
Elif Car, Isabelle Huys, Steven Simoens, Arnold G. Vulto   +3 more
wiley   +1 more source

Explaining the decline in coronary heart disease mortality rates in the Slovak Republic between 1993-2008. [PDF]

PLoS One, 2018
Psota M, Bandosz P, Gonçalvesová E, Avdičová M, Bucek Pšenková M, Studenčan M, Pekarčíková J, Capewell S, O'Flaherty M.   +8 more
europepmc   +1 more source

Clinical and molecular features of PRCD‐associated retinopathy

Acta Ophthalmologica, EarlyView.
Abstract Purpose To describe the clinical and genetic characteristics of patients with biallelic disease‐causing variants in the PRCD (Progressive Rod‐Cone Degeneration) gene. Methods Multicentre, retrospective cohort study of 19 patients from 13 families across nine reference centres in six countries.
Vasil Kostin, Karolina Kaminska, Marco Cattaneo, Enrico Ambrosini, Carmen Ayuso, Almudena Ávila‐Fernández, Béatrice Bocquet, Luisa Coutinho‐Santos, Benedetto Falsini, Lidia Fernandez‐Caballero Palomeque, Bohdan Kousal, Petra Liskova, Inmaculada Martín‐Mérida, María Juliana Ballesta‐Martínez, Daan Panneman, Susanne Roosing, Isabelle Meunier, José M. Millán, Monika Pankievič, Irene Perea‐Romero, Virginie Peter, Giorgio Placidi, Cristina Santos, Francesca Simonelli, Ana Berta Sousa, Francesco Testa, Marie Vajter, Marianna Weener, Mathieu Quinodoz, Carlo Rivolta, Giacomo Calzetti   +30 more
wiley   +1 more source